News

The Ten Most Popular ProMarket Articles From 2024

ProMarket published 257 articles in 2024. Revisit some of our most popular pieces. 10. Erik Hovenkamp: What Does the Google Antitrust Decision Mean and Where Will It...

Five Popular Stigler Center (Non-conference) Events From 2024

A look back at some of the popular webinars, minicourses, and conversations the Stigler Center hosted in 2024.

Top Five Capitalisn’t Episodes From 2024

Here are the most-listened-to Capitalisn’t episodes from 2024.

Unconditional Revenue-Sharing By Google Would Still Be Anticompetitive Monopolization

Steven C. Salop argues that as part of any remedy outcome from the Google Search case, Google cannot be permitted to enter agreements with...

The Trends and Cases That Defined European Antitrust in 2024

Three antitrust experts review the trends and cases that defined European antitrust and competition in 2024. Apple’s unfair trading conditions and the Digital Markets Act Alessia...

The Trends and Cases That Defined United States Antitrust in 2024

Three antitrust experts review the trends and cases that defined United States antitrust in 2024.

A New Vision of EU Competition Policy Is Incomplete Without Central-Eastern Europe

The ongoing debates about the EU’s competition policy have predominantly focused on Western Europe, overlooking the dynamic growth and unique challenges of Central and Eastern Europe, writes Maciej Bernatt and Kati Cseres. This oversight risks deepening economic disparities and undermining the EU’s goals of unity, democracy, and innovation-driven growth.

How Thousands of Tech and Pharma Mergers Escape Antitrust Scrutiny

New research from Christopher Stewart, John Kepler, and Charles McClure shows that thousands of large mergers and acquisitions bypass antitrust review because current regulatory thresholds ignore intangible assets like intellectual property and customer data. These unreported deals, particularly in tech and pharma sectors, show signs of being more anticompetitive - with higher premiums paid, increased market power for acquirers, and evidence of "killer acquisitions" in pharmaceuticals.

Trump 2.0 Will Challenge the European “Competition Safe Spaces”

Despite fundamental changes in the real economy, and strides in the regulation of privacy, data, and digital markets, antitrust practice and discourse in Europe are still conducted in “safe spaces” where the antitrust community resists change and remains attached to neoliberal approaches and efficiency goals. But the Trump Administration will not just signify a wholesale return to pre-NeoBrandeisian times (as many in Europe hope): indeed Europeans hiding in their “safe spaces” may well be surprised, writes Cristina Caffarra.

Tracking SEC Movements Sheds Light on Investigatory Process and Its Impact on Firms

In new research, William Christopher Gerken, Steven Irlbeck, Marcus Painter and Guangli Zhang track the movements of Securities and Exchange Commission-associated smartphone devices to shed light on the SEC’s investigatory process and understand how office visits from its staff alter firm behavior and outcomes.

Latest news